The comparative safety of analgesics in older adults with arthritis.

PubWeight™: 4.47‹?› | Rank: Top 1%

🔗 View Article (PMID 21149752)

Published in Arch Intern Med on December 13, 2010

Authors

Daniel H Solomon1, Jeremy A Rassen, Robert J Glynn, Joy Lee, Raisa Levin, Sebastian Schneeweiss

Author Affiliations

1: Division of Pharmacoepidemiology, Brigham and Women's Hospital, Boston, MA 02115, USA. dsolomon@partners.org

Associated clinical trials:

Geriatric Ketamine for Pain Management Study | NCT02673372

Articles citing this

Opioid-Prescribing Patterns of Emergency Physicians and Risk of Long-Term Use. N Engl J Med (2017) 3.16

Greater number of narcotic analgesic prescriptions for osteoarthritis is associated with falls and fractures in elderly adults. J Am Geriatr Soc (2013) 2.17

Older US emergency department patients are less likely to receive pain medication than younger patients: results from a national survey. Ann Emerg Med (2011) 2.15

National cohort study of opioid analgesic dose and risk of future hospitalization. J Hosp Med (2015) 2.06

Long-term opioid therapy reconsidered. Ann Intern Med (2011) 1.77

Covariate selection in high-dimensional propensity score analyses of treatment effects in small samples. Am J Epidemiol (2011) 1.72

The modern pharmacology of paracetamol: therapeutic actions, mechanism of action, metabolism, toxicity and recent pharmacological findings. Inflammopharmacology (2013) 1.56

Management of persistent pain in the older patient: a clinical review. JAMA (2014) 1.54

Use of opioids and other analgesics by older adults in the United States, 1999-2010. Pain Med (2014) 1.52

Prescription of Long-Acting Opioids and Mortality in Patients With Chronic Noncancer Pain. JAMA (2016) 1.50

Canadian guideline for safe and effective use of opioids for chronic noncancer pain: clinical summary for family physicians. Part 2: special populations. Can Fam Physician (2011) 1.41

The next therapeutic challenge in HIV: polypharmacy. Drugs Aging (2013) 1.30

Improving the pharmacologic management of pain in older adults: identifying the research gaps and methods to address them. Pain Med (2011) 1.25

Adverse effects of analgesics commonly used by older adults with osteoarthritis: focus on non-opioid and opioid analgesics. Am J Geriatr Pharmacother (2012) 1.22

Primary care providers' perspective on prescribing opioids to older adults with chronic non-cancer pain: a qualitative study. BMC Geriatr (2011) 1.18

Older adults are mobile too!Identifying the barriers and facilitators to older adults' use of mHealth for pain management. BMC Geriatr (2013) 1.14

Opioid prescribing by multiple providers in Medicare: retrospective observational study of insurance claims. BMJ (2014) 1.10

Receipt of opioid analgesics by HIV-infected and uninfected patients. J Gen Intern Med (2012) 1.02

Medication use and functional status decline in older adults: a narrative review. Am J Geriatr Pharmacother (2011) 0.97

The Association Between Receipt of Guideline-Concordant Long-Term Opioid Therapy and All-Cause Mortality. J Gen Intern Med (2016) 0.95

Shared decision-making in the selection of outpatient analgesics for older individuals in the emergency department. J Am Geriatr Soc (2013) 0.94

Trends in prescription of opioids from 2003-2009 in persons with knee osteoarthritis. Arthritis Care Res (Hoboken) (2014) 0.93

A Review of Potential Adverse Effects of Long-Term Opioid Therapy: A Practitioner's Guide. Prim Care Companion CNS Disord (2012) 0.89

Opioids for chronic noncancer pain in the elderly: an osteoarthritis case. Can Fam Physician (2011) 0.88

Viscosupplementation for osteoarthritis: a primer for primary care physicians. Adv Ther (2013) 0.88

Complementary therapies for osteoarthritis: are they effective? Pain Manag Nurs (2012) 0.88

Impact of prescribed medications on patient safety in older people. Ther Adv Drug Saf (2012) 0.88

Duloxetine in the management of diabetic peripheral neuropathic pain. Patient Prefer Adherence (2011) 0.87

Long-term Prescription of Opioids and/or Benzodiazepines and Mortality Among HIV-Infected and Uninfected Patients. J Acquir Immune Defic Syndr (2015) 0.86

Year in review: medication mishaps in the elderly. Am J Geriatr Pharmacother (2011) 0.86

Non-steroidal anti-inflammatory drugs for the treatment of pain and immobility-associated osteoarthritis: consensus guidance for primary care. BMC Fam Pract (2012) 0.85

A painful setback: misinterpretation of analgesic safety in older adults may inadvertently worsen pain care. Arch Intern Med (2011) 0.85

Trends in Any and High-Dose Opioid Analgesic Receipt Among Aging Patients With and Without HIV. AIDS Behav (2016) 0.85

Nonsteroidal anti-inflammatory drugs, gastroprotection, and benefit-risk. Pain Pract (2013) 0.84

Polypharmacy in the elderly from the clinical toxicologist perspective. Z Gerontol Geriatr (2012) 0.82

Meeting the public health challenge of pain in later life: what role can senior centers play? Pain Manag Nurs (2013) 0.81

Reconsideration of key articles regarding medication-related problems in older adults from 2011. Am J Geriatr Pharmacother (2012) 0.81

Association of Opioids with Falls, Fractures, and Physical Performance among Older Men with Persistent Musculoskeletal Pain. J Gen Intern Med (2016) 0.81

Primary care management of opioid use disorders: Abstinence, methadone, or buprenorphine-naloxone? Can Fam Physician (2017) 0.80

Implementing a cognitive-behavioral pain self-management program in home health care, part 1: program adaptation. J Geriatr Phys Ther (2013) 0.80

[DGRh recommendations for the implementation of current security aspects in the NSAID treatment of musculoskeletal pain]. Z Rheumatol (2016) 0.80

Managing osteoarthritis. Aust Prescr (2015) 0.79

The safety of opioid analgesics in the elderly: new data raise new concerns: comment on "The comparative safety of opioids for nonmalignant pain in older adults". Arch Intern Med (2010) 0.79

Discharge Hospice Referral and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries Hospitalized for Heart Failure. Circ Heart Fail (2015) 0.79

"Safe and effective when used as directed": the case of chronic use of opioid analgesics. J Med Toxicol (2012) 0.78

Pharmacologic management of osteoarthritis-related pain in older adults. Am J Nurs (2012) 0.78

[Opioids for noncancer pain in the elderly]. Schmerz (2015) 0.78

Influence of central nervous system-acting drugs on results of cognitive testing in geriatric inpatients. Z Gerontol Geriatr (2014) 0.77

Hospital Prescribing of Opioids to Medicare Beneficiaries. JAMA Intern Med (2016) 0.77

Neuropathic Pain due to Small Fiber Neuropathy in Aging: Current Management and Future Prospects. Drugs Aging (2015) 0.77

Model-based evaluation of cost-effectiveness of nerve growth factor inhibitors in knee osteoarthritis: impact of drug cost, toxicity, and means of administration. Osteoarthritis Cartilage (2015) 0.77

Pharmacologic Management of Osteoarthritis-Related Pain in Older Adults: A Review Shows that Many Drug Therapies Provide Small-to-Modest Pain Relief. HSS J (2012) 0.77

Combined glucosamine and chondroitin sulfate, once or three times daily, provides clinically relevant analgesia in knee osteoarthritis. Clin Rheumatol (2014) 0.77

Opioids contribute to fracture risk: a meta-analysis of 8 cohort studies. PLoS One (2015) 0.77

[Quality and appropriateness of pain medication. Instrument for estimation in nursing home residents]. Schmerz (2013) 0.76

Pharmacologic treatment of hand-, knee- and hip-osteoarthritis. Wien Med Wochenschr (2013) 0.76

[Treatment of cardiovascular risk factors]. Z Rheumatol (2016) 0.76

Pain, analgesics, and safety in patients with CKD. Clin J Am Soc Nephrol (2015) 0.75

Safety of opioids in older adults. Arch Intern Med (2011) 0.75

Opioids for osteoarthritis pain: benefits and risks. Can Fam Physician (2012) 0.75

Pharmacological Approaches for the Management of Persistent Pain in Older Adults: What Nurses Need to Know. J Gerontol Nurs (2016) 0.75

Incident user cohorts for assessing medication cost-offsets. Health Serv Res (2014) 0.75

Tramadol and the risk of fracture in an elderly female population: a cost utility assessment with comparison to transdermal buprenorphine. Eur J Health Econ (2015) 0.75

Brief Report: Longitudinal Opioid Use Among HIV-Infected Patients, 2000 to 2014. J Acquir Immune Defic Syndr (2017) 0.75

Higher Prescription Opioid Dose is Associated With Worse Patient-Reported Pain Outcomes and More Health Care Utilization. J Pain (2016) 0.75

Pharmacotherapy: comparative safety of nonsteroidal anti-inflammatory drugs. Nat Rev Cardiol (2011) 0.75

Cost-Effectiveness of Tramadol and Oxycodone in the Treatment of Knee Osteoarthritis. Arthritis Care Res (Hoboken) (2016) 0.75

Opioids versus nonsteroidal anti-inflammatory drugs in noncancer pain. Can Fam Physician (2012) 0.75

Analgesic use in the elderly: the "pain" and simple truth: comment on "The comparative safety of analgesics in older adults with arthritis". Arch Intern Med (2010) 0.75

Matching Weights to Simultaneously Compare Three Treatment Groups: Comparison to Three-way Matching. Epidemiology (2017) 0.75

The feasibility of matching on a propensity score for acupuncture in a prospective cohort study of patients with chronic pain. BMC Med Res Methodol (2017) 0.75

Non-steroidal anti-inflammatory drugs and their benefits and harms: the challenge of interpreting meta-analyses and observational data sets when balanced data are not analyzed and reported. Arthritis Res Ther (2015) 0.75

Pain severity predicts depressive symptoms over and above individual illnesses and multimorbidity in older adults. BMC Psychiatry (2017) 0.75

Can Fam Physician (2017) 0.75

The Trend-in-Trend Research Design for Causal Inference. Epidemiology (2016) 0.75

[Medications]. Orthopade (2012) 0.75

Prescribed opioids in primary care: cross-sectional and longitudinal analyses of influence of patient and practice characteristics. BMJ Open (2016) 0.75

Implementing a Pain Self-Management Protocol in Home Care: A Cluster-Randomized Pragmatic Trial. J Am Geriatr Soc (2017) 0.75

Articles by these authors

Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein. N Engl J Med (2008) 43.36

Variable selection for propensity score models. Am J Epidemiol (2006) 10.68

Reduction in C-reactive protein and LDL cholesterol and cardiovascular event rates after initiation of rosuvastatin: a prospective study of the JUPITER trial. Lancet (2009) 10.52

Long-term, low-intensity warfarin therapy for the prevention of recurrent venous thromboembolism. N Engl J Med (2003) 8.65

Risk of death in elderly users of conventional vs. atypical antipsychotic medications. N Engl J Med (2005) 8.44

Vitamins E and C in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA (2008) 8.32

High-dimensional propensity score adjustment in studies of treatment effects using health care claims data. Epidemiology (2009) 7.40

A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods. J Clin Epidemiol (2005) 7.31

Long-term persistence in use of statin therapy in elderly patients. JAMA (2002) 7.19

Accuracy of Medicare claims-based diagnosis of acute myocardial infarction: estimating positive predictive value on the basis of review of hospital records. Am Heart J (2004) 6.57

Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol (2005) 6.20

A randomized study of how physicians interpret research funding disclosures. N Engl J Med (2012) 5.47

Multivitamins in the prevention of cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA (2012) 5.25

Vitamins E and C in the prevention of prostate and total cancer in men: the Physicians' Health Study II randomized controlled trial. JAMA (2008) 5.13

Antidepressant use in pregnancy and the risk of cardiac defects. N Engl J Med (2014) 4.99

Risk of death and cardiovascular events in initially healthy women with new-onset atrial fibrillation. JAMA (2011) 4.73

Indications for propensity scores and review of their use in pharmacoepidemiology. Basic Clin Pharmacol Toxicol (2006) 4.70

Full coverage for preventive medications after myocardial infarction. N Engl J Med (2011) 4.51

Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial. Lancet (2012) 4.46

Multivitamins in the prevention of cardiovascular disease in men: the Physicians' Health Study II randomized controlled trial. JAMA (2012) 4.40

Statins for the primary prevention of cardiovascular events in women with elevated high-sensitivity C-reactive protein or dyslipidemia: results from the Justification for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin (JUPITER) and meta-analysis of women from primary prevention trials. Circulation (2010) 4.37

HDL cholesterol and residual risk of first cardiovascular events after treatment with potent statin therapy: an analysis from the JUPITER trial. Lancet (2010) 4.07

Outcomes of reference pricing for angiotensin-converting-enzyme inhibitors. N Engl J Med (2002) 4.07

Depression and risk of sudden cardiac death and coronary heart disease in women: results from the Nurses' Health Study. J Am Coll Cardiol (2009) 3.99

A combined comorbidity score predicted mortality in elderly patients better than existing scores. J Clin Epidemiol (2011) 3.98

Anticonvulsant medications and the risk of suicide, attempted suicide, or violent death. JAMA (2010) 3.85

The epidemiology of prescriptions abandoned at the pharmacy. Ann Intern Med (2010) 3.78

Evaluating short-term drug effects using a physician-specific prescribing preference as an instrumental variable. Epidemiology (2006) 3.54

Analytic strategies to adjust confounding using exposure propensity scores and disease risk scores: nonsteroidal antiinflammatory drugs and short-term mortality in the elderly. Am J Epidemiol (2005) 3.33

The implications of therapeutic complexity on adherence to cardiovascular medications. Arch Intern Med (2011) 3.27

Blood pressure and risk of developing type 2 diabetes mellitus: the Women's Health Study. Eur Heart J (2007) 3.21

Cardiovascular outcomes and mortality in patients using clopidogrel with proton pump inhibitors after percutaneous coronary intervention or acute coronary syndrome. Circulation (2009) 3.09

Tumor necrosis factor alpha antagonist use and cancer in patients with rheumatoid arthritis. Arthritis Rheum (2006) 3.04

High-density lipoprotein cholesterol, size, particle number, and residual vascular risk after potent statin therapy. Circulation (2013) 3.03

Association between disease-modifying antirheumatic drugs and diabetes risk in patients with rheumatoid arthritis and psoriasis. JAMA (2011) 3.02

Confounding control in healthcare database research: challenges and potential approaches. Med Care (2010) 3.01

Relationship between selective cyclooxygenase-2 inhibitors and acute myocardial infarction in older adults. Circulation (2004) 2.98

Efficacy of rosuvastatin among men and women with moderate chronic kidney disease and elevated high-sensitivity C-reactive protein: a secondary analysis from the JUPITER (Justification for the Use of Statins in Prevention-an Intervention Trial Evaluating Rosuvastatin) trial. J Am Coll Cardiol (2010) 2.93

Hetastarch and bleeding complications after coronary artery surgery. Chest (2003) 2.87

Noncompliance with antihypertensive medications: the impact of depressive symptoms and psychosocial factors. J Gen Intern Med (2002) 2.85

Nonsteroidal anti-inflammatory drug use and acute myocardial infarction. Arch Intern Med (2002) 2.82

Selective prescribing led to overestimation of the benefits of lipid-lowering drugs. J Clin Epidemiol (2006) 2.81

Treatment effects in the presence of unmeasured confounding: dealing with observations in the tails of the propensity score distribution--a simulation study. Am J Epidemiol (2010) 2.74

Inhibition of clinical benefits of aspirin on first myocardial infarction by nonsteroidal antiinflammatory drugs. Circulation (2003) 2.73

The comparative safety of opioids for nonmalignant pain in older adults. Arch Intern Med (2010) 2.71

Comparative mortality risk of anemia management practices in incident hemodialysis patients. JAMA (2010) 2.71

The U.S. Food and Drug Administration's Mini-Sentinel program: status and direction. Pharmacoepidemiol Drug Saf (2012) 2.70

Identification of individuals with CKD from Medicare claims data: a validation study. Am J Kidney Dis (2005) 2.65

Improved comorbidity adjustment for predicting mortality in Medicare populations. Health Serv Res (2003) 2.65

Improvements in long-term mortality after myocardial infarction and increased use of cardiovascular drugs after discharge: a 10-year trend analysis. J Am Coll Cardiol (2008) 2.58

Excess weight and the risk of incident coronary heart disease among men and women. Obesity (Silver Spring) (2009) 2.56

Performance of propensity score calibration--a simulation study. Am J Epidemiol (2007) 2.56

Adjusting effect estimates for unmeasured confounding with validation data using propensity score calibration. Am J Epidemiol (2005) 2.55

Repeated hospitalizations predict mortality in the community population with heart failure. Am Heart J (2007) 2.55

Medicaid prior-authorization programs and the use of cyclooxygenase-2 inhibitors. N Engl J Med (2004) 2.52

Incorporation of clustering effects for the Wilcoxon rank sum test: a large-sample approach. Biometrics (2003) 2.49

Statin adherence and risk of accidents: a cautionary tale. Circulation (2009) 2.47

Evaluating uses of data mining techniques in propensity score estimation: a simulation study. Pharmacoepidemiol Drug Saf (2008) 2.42

Long-term multivitamin supplementation and cognitive function in men: a randomized trial. Ann Intern Med (2013) 2.39

Adjusting for unmeasured confounders in pharmacoepidemiologic claims data using external information: the example of COX2 inhibitors and myocardial infarction. Epidemiology (2005) 2.38

Anti-tumor necrosis factor alpha therapy and the risk of serious bacterial infections in elderly patients with rheumatoid arthritis. Arthritis Rheum (2007) 2.37

Racial differences in screening for prostate cancer in the elderly. Arch Intern Med (2004) 2.34

Increasing levels of restriction in pharmacoepidemiologic database studies of elderly and comparison with randomized trial results. Med Care (2007) 2.31

Influence of systolic and diastolic blood pressure on the risk of incident atrial fibrillation in women. Circulation (2009) 2.26

Preference-based instrumental variable methods for the estimation of treatment effects: assessing validity and interpreting results. Int J Biostat (2007) 2.24

A randomized trial of beta carotene supplementation and cognitive function in men: the Physicians' Health Study II. Arch Intern Med (2007) 2.20

Treatment of older adult patients diagnosed with rheumatoid arthritis: improved but not optimal. Arthritis Rheum (2007) 2.18

Use of topiramate in pregnancy and risk of oral clefts. Am J Obstet Gynecol (2012) 2.14

Patterns of medication initiation in newly diagnosed diabetes mellitus: quality and cost implications. Am J Med (2012) 2.13

Assessing health state utilities in elderly patients at cardiovascular risk. Med Decis Making (2006) 2.12

Trouble getting started: predictors of primary medication nonadherence. Am J Med (2011) 2.09

Which patients with unstable angina or non-Q-wave myocardial infarction should have immediate cardiac catheterization? A clinical decision rule for predicting who will fail medical therapy. J Clin Epidemiol (2002) 2.09

C-reactive protein levels among women of various ethnic groups living in the United States (from the Women's Health Study). Am J Cardiol (2004) 2.08

A prospective study of serum lipids and risk of diabetic macular edema in type 1 diabetes. Diabetes (2004) 2.03